BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fuente RAL, Gutiérrez ML, Garcia-Samaniego J, Fernández-Rodriguez C, Lledó JL, Castellano G. Pathogenesis of occult chronic hepatitis B virus infection. World J Gastroenterol 2011; 17(12): 1543-1548 [PMID: 21472118 DOI: 10.3748/wjg.v17.i12.1543]
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1543.htm
Number Citing Articles
1
Abdulrasheed Usman, Bukhari Isah Shuaib, Bolanle O. P. Musa, Sani Awwal, Sunday Akogwu. Seroprevalence of Occult Hepatitis B Virus Infection Using Anti-HBc and Nucleic Acid Amplification (HBV DNA) Technique in a Resource-Limited Setting: a Systematic Review and Meta-Analysis of Nigerian LiteratureSN Comprehensive Clinical Medicine 2022; 5(1) doi: 10.1007/s42399-022-01359-y
2
Ajeet Singh Bhadoria, Chandan Kumar Kedarisetty, Chhagan Bihari, Guresh Kumar, Ankur Jindal, Ankit Bhardwaj, Varsha Shasthry, Jaya Benjamin, Manoj Kumar Sharma, Shiv Kumar Sarin. Positive familial history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross‐sectional studyLiver International 2019; 39(1): 168 doi: 10.1111/liv.13958
3
Ziba Shabani, Masomeh Bagheri, Mohammad Zare-Bidaki, Gholamhossein Hassanshahi, Mohammad Kazemi Arababadi, Mozafar Mohammadi Nejad, Derek Kennedy. NK cells in hepatitis B virus infection: a potent target for immunotherapyArchives of Virology 2014; 159(7): 1555 doi: 10.1007/s00705-013-1965-3
4
Masoud Karimi‐Googheri, Hamid Daneshvar, Reza Nosratabadi, Mohammad Zare‐Bidaki, Gholamhossein Hassanshahi, Maryam Ebrahim, Mohammad Kazemi Arababadi, Derek Kennedy. Important roles played by TGF‐β in hepatitis B infectionJournal of Medical Virology 2014; 86(1): 102 doi: 10.1002/jmv.23727
5
Mehdi Zobeiri. Occult Hepatitis B: Clinical Viewpoint and ManagementHepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/259148
6
Edina Amponsah‐Dacosta, Selokela G. Selabe, Maphahlaganye J. Mphahlele. Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co‐infected patientsJournal of Medical Virology 2018; 90(2): 291 doi: 10.1002/jmv.24956
7
Jin-Wook Kim. Occult hepatitis B virus infection: clearance or disguise?Clinical and Molecular Hepatology 2014; 20(3): 249 doi: 10.3350/cmh.2014.20.3.249
8
Carlos Mario Jaramillo, Fernando de La Hoz, Alexandra Porras, Diana di Filippo, Luz Angela Choconta-Piraquive, Edra Payares, Neyla Montes, Maria-Cristina Navas, Pierre Roques. Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, ColombiaPLOS ONE 2017; 12(10): e0181643 doi: 10.1371/journal.pone.0181643
9
Noor A. Kazim, Kareem M. Lilo, Shaima R. Ibraheem, Yaqoob A. Saleh, Sally B. Shabeeb. EVALUATION OF SEROLOGICAL SCREENING AND PCR-AMPLIFICATION OF HEPATITIS B VIRUS DNA AMONG IRAQI BLOOD DONORSWiadomości Lekarskie 2022; 75(12): 2915 doi: 10.36740/WLek202212104
10
Ling Li, Rui Wang, Jin Guo, Liu He, Zhengmin Liu, Qianqian Qin, Jing Zhang, Shuo Wu, Liqin Huang, Hongwei Ge, Zhong Liu. Suggested blood donor deferral strategy regarding hepatitis B infections in ChinaTransfusion Medicine 2024; 34(2): 136 doi: 10.1111/tme.13030
11
Shashi A. Gujar, Patricia M. Mulrooney-Cousins, Tomasz I. Michalak. Repeated Exposure to Trace Amounts of Woodchuck Hepadnavirus Induces Molecularly Evident Infection and Virus-Specific T Cell Response in the Absence of Serological Infection Markers and HepatitisJournal of Virology 2013; 87(2): 1035 doi: 10.1128/JVI.01363-12
12
Mohammad Kazemi Arababadi, Mohammad Zare Bidaki, Derek Kennedy. IL-17A in hepatitis B infection: friend or foe?Archives of Virology 2014; 159(8): 1883 doi: 10.1007/s00705-014-2002-x
13
Félix P.D. Pinto, Orlando C. Ferreira Jr., Daniele B. Olmedo, Patrícia M. Precioso, Fernanda R.S. Barquette, Magda C. Castilho, Suely G.C. Silva, Luís Cristóvão Pôrto. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional studyAnnals of Hepatology 2015; 14(6): 815 doi: 10.5604/16652681.1171756
14
Ebrahim Eskandari, Malihe Metanat, Elham Pahlevani, Tooba Nakhzari-Khodakheir. Association between TGFβ1 polymorphisms and chronic hepatitis B infection in an Iranian populationRevista da Sociedade Brasileira de Medicina Tropical 2017; 50(3): 301 doi: 10.1590/0037-8682-0266-2016
15
Rasoul Estakhri, Mohamad Ali Somi, Ali Taban, Mohamad Goldust. WITHDRAWN: Evaluation of correlation between serum immunoglobulin levels and extent of hepatic fibrosis in patients with chronic B and C hepatitisPathology - Research and Practice 2013;  doi: 10.1016/j.prp.2013.05.006
16
Amanda Abramson, Alan Menter, Robert Perrillo. Psoriasis, hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for managementJournal of the American Academy of Dermatology 2012; 67(6): 1349 doi: 10.1016/j.jaad.2012.04.036
17
Francisca Sosa-Jurado, Daniel Meléndez-Mena, Nora H. Rosas-Murrieta, Belinda Guzmán-Flores, Miguel A. Mendoza-Torres, Roberto Barcenas-Villalobos, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Julio Reyes-Leyva, Verónica Vallejo-Ruiz, Gerardo Santos-López, Isabelle Chemin. Effectiveness of PCR primers for the detection of occult hepatitis B virus infection in Mexican patientsPLOS ONE 2018; 13(10): e0205356 doi: 10.1371/journal.pone.0205356
18
Amadin A. Olotu, Adesola O. Oyelese, Lateef Salawu, Rosemary A. Audu, Azuka P. Okwuraiwe, Aaron O. Aboderin. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantationVirology Journal 2016; 13(1) doi: 10.1186/s12985-016-0533-3
19
Ajeet S. Bhadoria, Chandan K. Kedarisetty, Chhagan Bihari, Guresh Kumar, Ankur Jindal, Ankit Bhardwaj, Varsha Shasthry, Tanmay Vyas, Jaya Benjamin, Shvetank Sharma, Manoj K. Sharma, Shiv K. Sarin. Impact of family history of metabolic traits on severity of non‐alcoholic steatohepatitis related cirrhosis: A cross‐sectional studyLiver International 2017; 37(9): 1397 doi: 10.1111/liv.13396
20
Jaime Morales-Romero, Gustavo Vargas, Rebeca García-Román. Occult HBV Infection: A Faceless Enemy in Liver Cancer DevelopmentViruses 2014; 6(4): 1590 doi: 10.3390/v6041590